Yee Chao

23.7k citations
346 papers · 11.3k · 3 hit papers · h-index 47

Impact in

  • Hepatology top 0.1%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Treatments and Studies

Papers in

    • Cancer Immunotherapy and Biomarkers 34
    • Colorectal Cancer Treatments and Studies 29
    • Pancreatic and Hepatic Oncology Research 24
    • Hepatocellular Carcinoma Treatment and Prognosis 78

Yee Chao

338 papers receiving 11.2k citations

Yee Chao's Hit Papers

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial 2019 · 1.3k citations
1.3k0+6+13Years since publication4008001.2k

Peers

Yee Chao
Comparison fields: 5 of 138
  • Hepatology 3.0k
  • Oncology 3.2k
  • Gastroenterology 523
  • Pulmonary and Respiratory Medicine 2.8k
  • Cancer Research 1.1k
Replace Jifeng Feng with:
Jifeng Feng China
Takashi Aikou Japan
Hidetoshi Eguchi Japan
Hiroshi Shimada Japan
Weijing Sun United States
Won Ki Kang South Korea
Wolff Schmiegel Germany
Hans Prenen Belgium
Masato Sakon Japan
Yoshiharu Sakai Japan
Yee Chao relative to Jifeng Feng China Jifeng Feng's profile →
Citations per field
00.5×4.5×
Jifeng Feng · 1×
Citations per year

Countries citing papers authored by Yee Chao

Since Specialization
Citations

This map shows the geographic impact of Yee Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yee Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yee Chao more than expected).

Fields of papers citing papers by Yee Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yee Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yee Chao. The network helps show where Yee Chao may publish in the future.

Co-authors

The 25 scholars most cited alongside Yee Chao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yee Chao Line = papers co-authored together Yee Chao links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 346 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group
Hit paper breakdown →
20061485
2
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Hit paper breakdown →
20191329
3
Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia
Hit paper breakdown →
2013368
4 2007208
5 2019189
6 2005177
7 2003163
8 2019159
9 2007158
10 2017153
11 2003152
12 2005150
13 2005133
14 2010132
15 1998101
16 2013100
17 2014100
18 199696
19
Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma.
199895
20 201191

About Yee Chao

Yee Chao is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 346 papers that have together received 11.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (78 papers), Gastric Cancer Management and Outcomes (66 papers), Cancer Immunotherapy and Biomarkers (34 papers), Colorectal Cancer Treatments and Studies (29 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (28 papers), Pancreatic and Hepatic Oncology Research (24 papers), Liver Disease Diagnosis and Treatment (19 papers) and Gastrointestinal Tumor Research and Treatment (16 papers). The work is most often cited by research in Hepatology (3.0k citations), Oncology (3.2k citations), Gastroenterology (523 citations), Pulmonary and Respiratory Medicine (2.8k citations) and Cancer Research (1.1k citations). Yee Chao has collaborated with scholars based in Taiwan, South Korea and United States. Frequent co-authors include Eric Van Cutsem, Sergei Tjulandin, Alejandro Majlis, Chung‐Pin Li, M Fodor, Vladimir Moiseyenko, Jaffer A. Ajani, Manuel Constenla, Э К Возный and C. Boni. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Gastroenterology and Hepatology, Journal of Hepatology and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact